{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:03:48Z","timestamp":1789556628506,"version":"build-2803163510"},"reference-count":50,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>With the continuous escalation of antimicrobial resistance, drug repurposing based on approved drugs has emerged as a promising strategy for the development of novel anti-infective agents. This study aimed to evaluate the antibacterial effect of the FDA-approved drug Ponatinib hydrochloride against multidrug-resistant S. aureus. Broth microdilution assay showed that ponatinib hydrochloride exhibited potent activity against Gram-positive bacteria, while the MICs against Gram-negative bacteria were all &gt;100 \u03bcM. In addition, the MICs against 15 clinical multidrug-resistant S. aureus isolates ranged from 6.25 to 25 \u03bcM. Time-kill assay further revealed a pronounced concentration- and time-dependent bactericidal effect, with bacterial viability reduced to nearly the detection limit within 24 h at 4 \u00d7 MIC. Anti-biofilm assays showed that ponatinib hydrochloride significantly inhibited S. aureus biofilm formation and disrupted mature biofilms. Moreover, serial passaging for 30 days did not induce an obvious increase in resistance. Mechanistic investigations demonstrated that ponatinib hydrochloride increased membrane permeability, induced intracellular reactive oxygen species (ROS) accumulation, and markedly reduced ATP levels. Finally, in a mouse infection model, ponatinib hydrochloride significantly improved the survival of infected mice, with a survival rate of 70% observed in the 15 mg\/kg treatment group, while also reducing bacterial burdens and pro-inflammatory cytokine levels in tissues. Collectively, ponatinib hydrochloride exhibits potent antibacterial activity against multidrug-resistant S. aureus both in vitro and in vivo and represents a promising candidate for anti-MRSA therapy.<\/jats:p>","DOI":"10.3390\/microorganisms14092066","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:09:17Z","timestamp":1789553357000},"page":"2066","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Repurposing Ponatinib Hydrochloride as an Antibacterial and Antibiofilm Agent Against Multidrug-Resistant Staphylococcus aureus"],"prefix":"10.3390","volume":"14","author":[{"given":"Xinhua","family":"Wang","sequence":"first","affiliation":[{"name":"College of Pharmacy, Heze University, Heze 274015, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Na","family":"Kong","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Heze University, Heze 274015, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"ref_1","first-page":"14","article-title":"Epidemiology, pathogenicity, animal infections, antibiotic resistance, public health significance, and economic impact of staphylococcus aureus: A comprehensive review","volume":"8","author":"Pal","year":"2020","journal-title":"Am. J. Public Health Res."},{"key":"ref_2","first-page":"1160","article-title":"Staphylococcus aureus: An overview of discovery, characteristics, epidemiology, virulence factors and antimicrobial sensitivity","volume":"8","author":"Rasheed","year":"2021","journal-title":"Eur. J. Mol. Clin. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"7641","DOI":"10.2147\/IDR.S428103","article-title":"Methicillin resistant Staphylococcus aureus: Molecular mechanisms underlying drug resistance development and novel strategies to combat","volume":"16","author":"Abebe","year":"2023","journal-title":"Infect. Drug Resist."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4103\/0255-0857.188313","article-title":"The changing face of community-acquired methicillin-resistant Staphylococcus aureus","volume":"34","author":"Kale","year":"2016","journal-title":"Indian J. Med. Microbiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"104915","DOI":"10.1016\/j.micpath.2021.104915","article-title":"Emerging resistance mechanisms for 4 types of common anti-MRSA antibiotics in Staphylococcus aureus: A comprehensive review","volume":"156","author":"Liu","year":"2021","journal-title":"Microb. Pathog."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Vestergaard, M., Frees, D., and Ingmer, H. (2019). Antibiotic resistance and the MRSA problem. Microbiol. Spectr., 7.","DOI":"10.1128\/microbiolspec.GPP3-0057-2018"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Kaushik, A., Kest, H., Sood, M., Steussy, B.W., Thieman, C., and Gupta, S. (2024). Biofilm producing methicillin-resistant Staphylococcus aureus (MRSA) infections in humans: Clinical implications and management. Pathogens, 13.","DOI":"10.3390\/pathogens13010076"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Salam, M.A., Al-Amin, M.Y., Salam, M.T., Pawar, J.S., Akhter, N., Rabaan, A.A., and Alqumber, M.A. (2023). Antimicrobial resistance: A growing serious threat for global public health. Healthcare, 11.","DOI":"10.20944\/preprints202305.0555.v1"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Mlynarczyk-Bonikowska, B., Kowalewski, C., Krolak-Ulinska, A., and Marusza, W. (2022). Molecular mechanisms of drug resistance in Staphylococcus aureus. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23158088"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41579-020-00443-1","article-title":"Proximate and ultimate causes of the bactericidal action of antibiotics","volume":"19","author":"Baquero","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41579-023-00877-3","article-title":"Bacterial defences: Mechanisms, evolution and antimicrobial resistance","volume":"21","author":"Smith","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.tim.2019.05.003","article-title":"Antimicrobial tolerance and metabolic adaptations in microbial biofilms","volume":"27","author":"Jensen","year":"2019","journal-title":"Trends Microbiol."},{"key":"ref_13","first-page":"1","article-title":"Drug repurposing for bacterial infections","volume":"Volume 207","author":"Ilyas","year":"2024","journal-title":"Progress in Molecular Biology and Translational Science"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1021\/acs.jmedchem.0c01786","article-title":"US FDA approved drugs from 2015\u2013June 2020: A perspective","volume":"64","author":"Bhutani","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2174\/1568026616666160930131737","article-title":"Repurposing of anticancer drugs for the treatment of bacterial infections","volume":"17","author":"Soo","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.2174\/1381612821666150506154434","article-title":"Repurposing non-antimicrobial drugs and clinical molecules to treat bacterial infections","volume":"21","author":"Younis","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.7150\/thno.56205","article-title":"Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria","volume":"11","author":"Liu","year":"2021","journal-title":"Theranostics"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Jin, Y., Xu, Z., Yan, H., He, Q., Yang, X., and Luo, P. (2020). A comprehensive review of clinical cardiotoxicity incidence of FDA-approved small-molecule kinase inhibitors. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.00891"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2217\/fon-2018-0371","article-title":"Ponatinib in the treatment of chronic myeloid leukemia and philadelphia chromosome positive acute lymphoblastic leukemia","volume":"15","author":"Pavlovsky","year":"2018","journal-title":"Future Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"148363","DOI":"10.1016\/j.ijbiomac.2025.148363","article-title":"Sorafenib and ponatinib as effective inhibitors of Fusobacterium nucleatum FtsZ: An in silico and in vitro study","volume":"330","author":"Fang","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Xu, F., Xie, Y., Yu, W., and Wang, Z. (2026). Breaking the outer membrane barrier: Structure, targets, and antimicrobial strategies for Gram-negative bacteria. Front. Microbiol., 17.","DOI":"10.3389\/fmicb.2026.1734749"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1021\/acsinfecdis.5c01108","article-title":"Targeting of the Gram-Negative Outer Membrane for Antibiotic Discovery and Potentiation","volume":"12","author":"Draveny","year":"2026","journal-title":"ACS Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"129113","DOI":"10.1016\/j.bmcl.2022.129113","article-title":"Overcoming intrinsic resistance in gram-negative bacteria using small molecule adjuvants","volume":"80","author":"Melander","year":"2023","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/lam.13213","article-title":"Antibacterial activity of chemotherapeutic drugs against Escherichia coli and Staphylococcus pseudintermedius","volume":"69","author":"Campbell","year":"2019","journal-title":"Lett. Appl. Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000057665","article-title":"Bactericidal effect of combinations of antibiotic and antineoplastic agents against Staphylococcus aureus and Escherichia coli","volume":"48","author":"Ljungberg","year":"2002","journal-title":"Chemotherapy"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jgar.2017.03.012","article-title":"Synergistic effect of non-steroidal anti-inflammatory drugs (NSAIDs) on antibacterial activity of cefuroxime and chloramphenicol against methicillin-resistant Staphylococcus aureus","volume":"10","author":"Chan","year":"2017","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"van Dun, S.C., Verheul, M., Pijls, B.G., van Prehn, J., Scheper, H., Galli, F., Nibbering, P.H., and de Boer, M.G. (2023). Influence of surface characteristics of implant materials on MRSA biofilm formation and effects of antimicrobial treatment. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1145210"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1093\/jac\/dkaf316","article-title":"Low bacterial metabolism as a central mechanism of antimicrobial resistance and potential therapeutic target of staphylococcal biofilms in ventricular assist device driveline infections","volume":"80","author":"Sun","year":"2025","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"104892","DOI":"10.1016\/j.micpath.2021.104892","article-title":"Anti-MRSA activity of curcumin in planktonic cells and biofilms and determination of possible action mechanisms","volume":"155","author":"Nogueira","year":"2021","journal-title":"Microb. Pathog."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Yuan, Z., Dai, Y., Ouyang, P., Rehman, T., Hussain, S., Zhang, T., Yin, Z., Fu, H., Lin, J., and He, C. (2020). Thymol inhibits biofilm formation, eliminates pre-existing biofilms, and enhances clearance of methicillin-resistant Staphylococcus aureus (MRSA) in a mouse peritoneal implant infection model. Microorganisms, 8.","DOI":"10.3390\/microorganisms8010099"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1128\/AAC.00181-13","article-title":"A combined pharmacodynamic quantitative and qualitative model reveals the potent activity of daptomycin and delafloxacin against Staphylococcus aureus biofilms","volume":"57","author":"Bauer","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/ptr.7275","article-title":"From plants to antimicrobials: Natural products against bacterial membranes","volume":"36","author":"Nourbakhsh","year":"2022","journal-title":"Phytother. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"116149","DOI":"10.1016\/j.ejmech.2024.116149","article-title":"Development of cannabidiol derivatives as potent broad-spectrum antibacterial agents with membrane-disruptive mechanism","volume":"266","author":"Fang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Guo, W., Zhao, Y., Yang, Y., Li, W., Wang, K., Zhou, F., Li, J., Li, X., Zhang, Y., and Hu, B. (2025). YZ462 exhibits potent antibacterial activity against methicillin-resistant Staphylococcus aureus through bacterial membrane disruption. BMC Microbiol., 25.","DOI":"10.1186\/s12866-025-04475-6"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Seixas, A.F., Quendera, A.P., Sousa, J.P., Silva, A.F., Arraiano, C.M., and Andrade, J.M. (2022). Bacterial response to oxidative stress and RNA oxidation. Front. Genet., 12.","DOI":"10.3389\/fgene.2021.821535"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e00208-24","DOI":"10.1128\/jb.00208-24","article-title":"Intracellular ATP concentration is a key regulator of bacterial cell fate","volume":"206","author":"Li","year":"2024","journal-title":"J. Bacteriol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.tim.2022.01.005","article-title":"Spotlight on FtsZ-based cell division in Archaea","volume":"30","author":"Ithurbide","year":"2022","journal-title":"Trends Microbiol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Chen, H., Zhang, J., He, Y., Lv, Z., Liang, Z., Chen, J., Li, P., Liu, J., Yang, H., and Tao, A. (2022). Exploring the role of Staphylococcus aureus in inflammatory diseases. Toxins, 14.","DOI":"10.3390\/toxins14070464"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1161\/CIRCRESAHA.122.321504","article-title":"Ponatinib drives cardiotoxicity by S100A8\/A9-NLRP3-IL-1\u03b2 mediated inflammation","volume":"132","author":"Tousif","year":"2023","journal-title":"Circ. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1158\/0008-5472.CAN-21-3652","article-title":"Reengineering ponatinib to minimize cardiovascular toxicity","volume":"82","author":"Hnatiuk","year":"2022","journal-title":"Cancer Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1073\/pnas.1504022112","article-title":"Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis","volume":"112","author":"Harbut","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Liu, Y., She, P., Xu, L., Chen, L., Li, Y., Liu, S., Li, Z., Hussain, Z., and Wu, Y. (2021). Antimicrobial, antibiofilm, and anti-persister activities of penfluridol against Staphylococcus aureus. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.727692"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.3892\/etm.2016.3486","article-title":"Antibacterial activity of oxyresveratrol against methicillin-resistant Staphylococcus aureus and its mechanism","volume":"12","author":"Joung","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ijantimicag.2017.03.020","article-title":"Repurposing Ivacaftor for treatment of Staphylococcus aureus infections","volume":"50","author":"Thakare","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e00720","DOI":"10.1002\/mbo3.720","article-title":"Efficacy of levofloxacin against biofilms of Pseudomonas aeruginosa isolated from patients with respiratory tract infections in vitro","volume":"8","author":"She","year":"2019","journal-title":"MicrobiologyOpen"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e00422-18","DOI":"10.1128\/mSphere.00422-18","article-title":"A high-throughput screening approach to repurpose FDA-approved drugs for bactericidal applications against Staphylococcus aureus small-colony variants","volume":"3","author":"Trombetta","year":"2018","journal-title":"mSphere"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/s41564-020-0723-z","article-title":"A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens","volume":"5","author":"Song","year":"2020","journal-title":"Nat. Microbiol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Wu, S.-C., Yang, Z.-Q., Liu, F., Peng, W.-J., Qu, S.-Q., Li, Q., Song, X.-B., Zhu, K., and Shen, J.-Z. (2019). Antibacterial effect and mode of action of flavonoids from licorice against methicillin-resistant Staphylococcus aureus. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.02489"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1902227","DOI":"10.1002\/advs.201902227","article-title":"Metformin Restores Tetracyclines Susceptibility against Multidrug Resistant Bacteria","volume":"7","author":"Liu","year":"2020","journal-title":"Adv. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1021\/acs.molpharmaceut.9b00293","article-title":"Evaluation of Platensimycin and Platensimycin-Inspired Thioether Analogues against Methicillin-Resistant Staphylococcus aureus in Topical and Systemic Infection Mouse Models","volume":"16","author":"Su","year":"2019","journal-title":"Mol. Pharm."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/14\/9\/2066\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:21:56Z","timestamp":1789554116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/14\/9\/2066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":50,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["microorganisms14092066"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms14092066","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]}}}